Common names in 25 European languages →
The complete database record: 2 documented constituents, 4 pharmacological actions, 9 traditional / indicated uses, with 15 cited sources.
Botanical Description
Robust, rhizomatous perennial herb (Asteraceae) that flowers before the leaves emerge: thick, pinkish, scaly flower spikes push up from the ground in early spring, followed by enormous rounded to heart-shaped leaves - up to about 1 m across at maturity - on stout stalks, giving rise to the common name 'umbrella plant'.[2]
Habitat & Distribution
Native to damp, marshy ground across Europe and western Asia - riverbanks, ditches, wet meadows and damp woodland margins - favouring moist, nutrient-rich soils.[2]
Harvesting
Rhizome/root is dug in autumn or early spring; leaves are gathered during the growing season. Raw material naturally contains hepatotoxic pyrrolizidine alkaloids, so commercial products are manufactured to remove them (PA-free standardised extracts); home-gathered material should never be used medicinally.[11]
Key Constituents
The anti-inflammatory and antispasmodic active principles; standardised in commercial extracts.
Naturally present but hepatotoxic and carcinogenic; must be removed to make a safe product.
Pharmacological Actions
Relief of allergic rhinitis / hay fever (antihistaminic and leukotriene-inhibiting; systematic review found it superior to placebo and comparable to non-sedating antihistamines for intermittent allergic rhinitis)
Traditional & Indicated Uses
Relief of allergic rhinitis / hay fever (antihistaminic and leukotriene-inhibiting; systematic review found it superior to placebo and comparable to non-sedating antihistamines for intermittent allergic rhinitis)
Antispasmodic support in bronchial asthma
inferred from anticancer action
more plants for cancer (anticancer research) →detailed sources →
Relief of allergic rhinitis / hay fever (antihistaminic and leukotriene-inhibiting; systematic review found it superior to placebo and comparable to non-sedating antihistamines for intermittent allergic rhinitis)
inferred from antispasmodic action
Migraine prophylaxis (reduces attack frequency; up to ~60% reduction vs placebo in a randomised controlled trial of a standardised CO2 root extract)
inferred from antispasmodic action
Traditional Use & History
Butterbur has a long European folk-medicine history as a fever remedy - the name 'pestilence wort' reflects its historic use during plague outbreaks - and for asthma, cough and migraine-type headache. Modern clinical trials of standardised, pyrrolizidine-alkaloid-free extracts support its use for migraine prevention and allergic rhinitis.[2, 3, 4]
Preparations
Dosage
Clinical trials have used standardised PA-free extracts (for example around 50-75 mg twice daily of a CO2 root extract for migraine prevention). Always use a certified PA-free commercial product, never raw plant material. Educational reference only, not a prescription.
Safety, Cautions & Contraindications
Use ONLY certified pyrrolizidine-alkaloid (PA)-free, standardised extracts. Raw or unprocessed butterbur contains PAs that are toxic to the liver and potentially carcinogenic.
Avoid during pregnancy and breastfeeding. As a member of the daisy family (Asteraceae), it can cause allergic reactions in people sensitive to ragweed and related plants. Watch for and report any signs of liver problems.
Dangerous Lookalikes
Harvest Readiness
[12]
[12]
External Identifiers
References & Sources
- Alhusayan, R.M., Aldahmash, B.A., El-Nagar, D.M., Rady, A. and others (2020) 'Butterbur (Petasites hybridus) Extract Ameliorates Hepatic Damage Induced by Ovalbumin in Mice', Oxidative Medicine and Cellular Longevity, 2020, pp. 3178214. doi:10.1155/2020/3178214 Preclinical
https://doi.org/10.1155/2020/3178214 - Kalin, P (2003) 'The common butterbur (Petasites hybridus)--portrait of a medicinal herb', Forschende Komplementarmedizin und Klassische Naturheilkunde, 10(Suppl 1), pp. 41-44. doi:10.1159/000071691 Meta-analysis / review
https://doi.org/10.1159/000071691 - Brattstrom, A (2003) 'A newly developed extract (Ze 339) from butterbur (Petasites hybridus L.) is clinically efficient in allergic rhinitis (hay fever)', Phytomedicine, 10(Suppl 4), pp. 50-52. doi:10.1078/1433-187x-00304 Meta-analysis / review
https://doi.org/10.1078/1433-187x-00304 - Lipton, R.B., Gobel, H., Einhaupl, K.M., Wilks, K. and Mauskop, A (2004) 'Petasites hybridus root (butterbur) is an effective preventive treatment for migraine', Neurology, 63(12), pp. 2240-2244. doi:10.1212/01.wnl.0000147290.68260.11 Randomized trial
https://doi.org/10.1212/01.wnl.0000147290.68260.11 - Apostolova, S., Oreshkova, T., Uzunova, V., Georgieva, I. and others (2023) 'A Standardized Extract of Petasites hybridus L., Containing the Active Ingredients Petasins, Acts as a Pro-Oxidant and Triggers Apoptosis through Elevating of NF-kB in a Highly Invasive Human Breast Cancer Cell Line', Frontiers in Bioscience (Landmark Edition), 28(6), pp. 111. doi:10.31083/j.fbl2806111 Preclinical
https://doi.org/10.31083/j.fbl2806111 - Danesch, U.C (2004) 'Petasites hybridus (Butterbur root) extract in the treatment of asthma--an open trial', Alternative Medicine Review, 9(1), pp. 54-62. Clinical study
https://scholar.google.com/scholar?q=Petasites%20hybridus%20%28Butterbur%20root%29%20extract%20in%20the%20treatment%20of%20asthma--an%20open%20trial - Aydin, A.A., Zerbes, V., Parlar, H. and Letzel, T (2013) 'The medical plant butterbur (Petasites): analytical and physiological (re)view', Journal of Pharmaceutical and Biomedical Analysis, 75, pp. 220-229. doi:10.1016/j.jpba.2012.11.028 Meta-analysis / review
https://doi.org/10.1016/j.jpba.2012.11.028 - Kulinowski, L., Luca, S.V., Minceva, M. and Skalicka-Wozniak, K (2022) 'A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L.)', Journal of Ethnopharmacology, 293, pp. 115263. doi:10.1016/j.jep.2022.115263 Meta-analysis / review
https://doi.org/10.1016/j.jep.2022.115263 - Alternative Medicine Review (2001) 'Monograph: Petasites hybridus', Alternative Medicine Review, 6(2), pp. 207-209. Meta-analysis / review
https://scholar.google.com/scholar?q=Monograph%3A%20Petasites%20hybridus - Kulinowski, L., Luca, S.V., Pecio, L., Minceva, M. and Skalicka-Wozniak, K (2023) 'Liquid-liquid chromatography isolation of Petasites hybridus sesquiterpenes and their LC-HR-MS/MS and NMR characterization', Journal of Pharmaceutical and Biomedical Analysis, 234, pp. 115529. doi:10.1016/j.jpba.2023.115529 Preclinical
https://doi.org/10.1016/j.jpba.2023.115529 - Sadler, C., Vanderjagt, L. and Vohra, S (2007) 'Complementary, holistic, and integrative medicine: butterbur', Pediatrics in Review. doi:10.1542/pir.28-6-235 Preclinical
https://doi.org/10.1542/pir.28-6-235 - Plants For A Future 'Petasites hybridus (Butterbur)'. Available at: https://pfaf.org/user/Plant.aspx?LatinName=Petasites+hybridus Traditional / reference
https://pfaf.org/user/Plant.aspx?LatinName=Petasites+hybridus - Guo, R. and Pittler, M.H. and Ernst, E (2007) 'Herbal medicines for the treatment of allergic rhinitis: a systematic review', Annals of Allergy, Asthma & Immunology, 99(6), pp. 483--495. doi:10.1016/S1081-1206(10)60375-4 Meta-analysis / review
https://doi.org/10.1016/S1081-1206(10)60375-4 - Grossmann, M. and Schmidramsl, H (2000) 'An extract of Petasites hybridus is effective in the prophylaxis of migraine', International Journal of Clinical Pharmacology and Therapeutics, 38(9), pp. 430--435. doi:10.5414/cpp38430 Randomized trial
https://doi.org/10.5414/cpp38430 - Sperl, W. and Stuppner, H. and Gassner, I. and Judmaier, W. and Dietze, O. and Vogel, W (1995) 'Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea', European Journal of Pediatrics, 154(2), pp. 112-6. doi:10.1007/BF01991912 Clinical study
https://doi.org/10.1007/BF01991912
Selected studies & references
All 13 studies in the Knowledge Finder →
This profile is assembled automatically from the Omnia Sana plant database, which we curate by hand. How this site is built.